13
Research Article Desymmetrization of Cyclic 1,3-Diketones under N-Heterocyclic Carbene Organocatalysis: Access to Organofluorines with Multiple Stereogenic Centers Guanjie Wang, 1 Min Zhang, 2 Yezhi Guan, 3 Ye Zhang, 1 Xianfang Hong, 1 Chenlong Wei, 1 Pengcheng Zheng , 4 Donghui Wei , 2 Zhenqian Fu , 1 Yonggui Robin Chi, 4,5 and Wei Huang 1,6 1 Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM) Nanjing Tech University (NanjingTech), 30 South Puzhu Road, Nanjing 211816, China 2 College of Chemistry and Green Catalysis Center, Zhengzhou University, Zhengzhou, Henan 450001, China 3 School of Chemistry and Molecular Engineering, Nanjing Tech University (NanjingTech), 30 South Puzhu Road, Nanjing 211816, China 4 Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Guizhou University, Huaxi District, Guiyang 550025, China 5 Division of Chemistry & Biological Chemistry, School of Physical & Mathematical Sciences, Nanyang Technological University, Singapore, Singapore 637371 6 Frontiers Science Center for Flexible Electronics (FSCFE) & Shaanxi Institute of Flexible Electronics (SIFE), Northwestern Polytechnical University (NPU), 127 West Youyi Road, Xian 710072, China Correspondence should be addressed to Pengcheng Zheng; [email protected], Donghui Wei; [email protected], Zhenqian Fu; [email protected], and Wei Huang; [email protected] Received 26 May 2021; Accepted 15 July 2021; Published 23 August 2021 Copyright © 2021 Guanjie Wang et al. Exclusive Licensee Science and Technology Review Publishing House. Distributed under a Creative Commons Attribution License (CC BY 4.0). Symmetric 1,3-diketones with uorine or uorinated substituents on the prochiral carbon remain to be established. Herein, we have developed a novel prochiral uorinated oxindanyl 1,3-diketone and successfully applied these substrates in carbene-catalyzed asymmetric desymmetrization. Accordingly, a versatile strategy for asymmetric generation of organouorines with uorine or uorinated methyl groups has been developed. Multiple stereogenic centers were selectively constructed with satisfactory outcomes. Structurally diverse enantioenriched organouorines were generated with excellent results in terms of yields, diastereoselectivities, and enantioselectivities. Notably, exchanging uorinated methyl groups to uorine for this prochiral 1,3-diketones leads to switchable stereoselectivity. Mechanistic aspects and origin of stereoselectivity were studied by DFT calculations. Notably, some of the prepared organouorines demonstrated competitive antibacterial activities. 1. Introduction Asymmetric desymmetrization represents one of the most facile and ecient methods for the generation of enantioen- riched organic compounds, especially with multiple stereo- genic centers, from meso or prochiral raw materials [14]. In this area, catalytic desymmetrization of prochiral 1,3-dike- tones has been investigated widely, including asymmetric reduction, intramolecular adol-type reactions, and others [521]. Furthermore, this desymmetric strategy as the key step has shown wide application in diverse natural product synthesis associated with diverse promising biological activi- ties [22, 23]. Owing to privileged structural characters of pro- chiral 1,3-diketones, such as containing unique and versatile carbonyl groups, and easily introducing substituents, further development of novel diverse prochiral diketones and their desymmetric strategies is still of high importance. Organic molecules with uorine or uorinated substituents can AAAS Research Volume 2021, Article ID 9867915, 13 pages https://doi.org/10.34133/2021/9867915

Desymmetrization of Cyclic 1,3-Diketones under N

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Desymmetrization of Cyclic 1,3-Diketones under N

Research ArticleDesymmetrization of Cyclic 1,3-Diketones under N-HeterocyclicCarbene Organocatalysis: Access to Organofluorines with MultipleStereogenic Centers

Guanjie Wang,1 Min Zhang,2 Yezhi Guan,3 Ye Zhang,1 Xianfang Hong,1 Chenlong Wei,1

Pengcheng Zheng ,4 Donghui Wei ,2 Zhenqian Fu ,1 Yonggui Robin Chi,4,5

and Wei Huang 1,6

1Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM) Nanjing Tech University (NanjingTech),30 South Puzhu Road, Nanjing 211816, China2College of Chemistry and Green Catalysis Center, Zhengzhou University, Zhengzhou, Henan 450001, China3School of Chemistry and Molecular Engineering, Nanjing Tech University (NanjingTech), 30 South Puzhu Road,Nanjing 211816, China4Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide andAgricultural Bioengineering, Ministry of Education, Guizhou University, Huaxi District, Guiyang 550025, China5Division of Chemistry & Biological Chemistry, School of Physical & Mathematical Sciences, Nanyang Technological University,Singapore, Singapore 6373716Frontiers Science Center for Flexible Electronics (FSCFE) & Shaanxi Institute of Flexible Electronics (SIFE),Northwestern Polytechnical University (NPU), 127 West Youyi Road, Xi’an 710072, China

Correspondence should be addressed to Pengcheng Zheng; [email protected], Donghui Wei; [email protected],Zhenqian Fu; [email protected], and Wei Huang; [email protected]

Received 26 May 2021; Accepted 15 July 2021; Published 23 August 2021

Copyright © 2021 Guanjie Wang et al. Exclusive Licensee Science and Technology Review Publishing House. Distributed under aCreative Commons Attribution License (CC BY 4.0).

Symmetric 1,3-diketones with fluorine or fluorinated substituents on the prochiral carbon remain to be established. Herein, we havedeveloped a novel prochiral fluorinated oxindanyl 1,3-diketone and successfully applied these substrates in carbene-catalyzedasymmetric desymmetrization. Accordingly, a versatile strategy for asymmetric generation of organofluorines with fluorine orfluorinated methyl groups has been developed. Multiple stereogenic centers were selectively constructed with satisfactoryoutcomes. Structurally diverse enantioenriched organofluorines were generated with excellent results in terms of yields,diastereoselectivities, and enantioselectivities. Notably, exchanging fluorinated methyl groups to fluorine for this prochiral1,3-diketones leads to switchable stereoselectivity. Mechanistic aspects and origin of stereoselectivity were studied by DFTcalculations. Notably, some of the prepared organofluorines demonstrated competitive antibacterial activities.

1. Introduction

Asymmetric desymmetrization represents one of the mostfacile and efficient methods for the generation of enantioen-riched organic compounds, especially with multiple stereo-genic centers, from meso or prochiral raw materials [1–4].In this area, catalytic desymmetrization of prochiral 1,3-dike-tones has been investigated widely, including asymmetricreduction, intramolecular adol-type reactions, and others

[5–21]. Furthermore, this desymmetric strategy as the keystep has shown wide application in diverse natural productsynthesis associated with diverse promising biological activi-ties [22, 23]. Owing to privileged structural characters of pro-chiral 1,3-diketones, such as containing unique and versatilecarbonyl groups, and easily introducing substituents, furtherdevelopment of novel diverse prochiral diketones and theirdesymmetric strategies is still of high importance. Organicmolecules with fluorine or fluorinated substituents can

AAASResearchVolume 2021, Article ID 9867915, 13 pageshttps://doi.org/10.34133/2021/9867915

Page 2: Desymmetrization of Cyclic 1,3-Diketones under N

significantly change their physical, chemical, and biologicalproperties [24–29]. For example, fluorocortisone, the firstfluorine-containing pharmaceutical, possesses remarkableglucocorticoid activity that exceeds the activities of the parenthormones by a factor of 10 [30]. Although fluorine is the13th most common element in the earth’s crust, it mainlyexists as inorganic salts. Indeed, the number of biogenicorganofluorines is extremely limited (around 20) [31].Therefore, organofluorine synthesis and application have

received tremendous attention in organic chemistry andachieved great advances [32–36]. Currently, a large numberof pharmaceuticals and agrochemicals involve at least onefluorine atom. Surprisingly, symmetric 1,3-diketones withfluorine or fluorinated substituents on the prochiral carbonare largely overlooked and remain to be established(Figure 1(a)).

Notably, prochiral 1,3-diketones possess several privi-leged advantages, including the following: (i) The acidic

Commercialfluorination reagents

H

FG

Significance of this new approach:

Replaceable various fluorine-containing substituents RF = CF3, CF2H, CH2F, F, SCF3t

Two adjacent challenging quaternary stereocenters with one fluorine-containing quaternary stereocenterVersatile approach to asymmetric synthesis of organofluorines

FG

FGChiral catalyst

Prochiral center preinstalledfluorine-containing unit

O O O

O

OH

RF

RF

O

RF = CF3, CF2H, CH2F, F, SCF3

RF

O O

O

O

(d)

(c)

(b)

(a)

NHC

> 59 examplesup to 96% yieldup to > 20:1 drup to > 99% ee

R H

O

O

R

NPG

Br

+

NPG

O

ORF

HOHO

H

H

Dexamethasone(treat inflammatory)

F

OHO

O

Sofosbuvir(HCV antiviral)

F

OO O

OHN

NOOO

PPhO HN

HOFluoroartemisinin

(antimalarial agents)

CF3

O O OO

Me

Me(X = OH, OR, O2CR, NHR)

Me

X

Me

Spindomycin A

HOO

ONH

MDM2-p53 inhibitor

OCl

Cl

EtO

NH

MeN

ONH

O

Gelsemine(toxic alkaloid)

Figure 1: Asymmetric desymmetrization of cyclic 1,3-diketone with fluorine functionalized groups: (a) our design on introducing fluorine orfluorinated substituents into symmetric 1,3-diketones; (b) this work: NHC-catalyzed asymmetric desymmetrization of fluorine functionalized1,3-diketones; (c) biologically active molecules with multiple stereogenic centers containing fluorine-containing quaternary stereocenter;(d) naturally occurring and biologically active spirocyclohexane oxindoles.

2 Research

Page 3: Desymmetrization of Cyclic 1,3-Diketones under N

prochiral carbon can be easily functionalized by deproton-ation with various commercially available fluorinationreagents (F, CF3, CF2H, CH2F, etc.) [37–42]. Catalytic asym-metric desymmetrization of these substrates ensures aversatile method for the synthesis of enantioenriched orga-nofluorines. Actually, it is challenging to be compatible withfluorine and fluorinated substituents in one asymmetric reac-tion due to their distinct properties. (ii) Asymmetricallymodifying one of the two ketone carbonyl groups leads tothe formation of fluorine-containing multiple stereogeniccenters. Notably, the synthesis of such great challengingmotifs has been largely underdeveloped, although they havealready appeared in several invaluable pharmaceuticals(Figure 1(c)) [36].

Given the significant success of asymmetric N-heterocy-clic carbene (NHC) catalysis [43–52] and privileged struc-tural characters of prochiral 1,3-diketones, based on ourongoing interest in organocatalysis [53–57], we envisioned

that a versatile method for the synthesis of enantioenrichedorganofluorines with multiple stereogenic centers might beestablished based on NHC-catalyzed asymmetric desymme-trization of novel prochiral fluorinated or fluoromethylatedoxindolyl 1,3-ketones. Notably, asymmetric synthesis ofspirocycle compounds has attracted a lot of synthetic atten-tion [58–61]. Among them, spiro compounds containingoxindole moieties are proven among the important scaffoldsin natural products and bioactive molecules exemplified bythose in Figure 1(d) [61, 62]. These easily available prochiral1,3-diketones could react with unsaturated acyl triazoliumintermediates [63–65] obtained from bromoenals withNHC to construct spiropolycyclic organofluorines with fivestereogenic centers, including three quaternary stereocenters.While one requirement would be to achieve intermoleculardomino desymmetrization, the connection of the reactive site(carbonyl group) to a sterically hindered quaternary carboncenter may impede this process. Furthermore, the ability to

Table 1: Optimized conditions[a].

O

OO

OO

OO

Y

O

3a2a

Solvent 0.1 M4 Å MS, 30°C, 24 h

1a

MHC‧HX (10 mol%)base 1.5 equiv

NMe

N

NN

A (Y = H)B (Y = Br)C (Y = NO2)

D E

N

NN

N

N

NN

MesMes MesBF4

BF4CI

Me

CF3CF3

Ph

O

Br

Ph

Ph

CHO

Entry[a] NHC·HX Base Solvent Yield (%)[b] dr[c] ee[d]

1 A K2CO3 Toluene 11 — —

2 A Cs2CO3 Toluene <10 — —

3 A Na2CO3 Toluene <10 — —

4 A NaHCO3 Toluene <10 — —

5 A DBU Toluene <10 — —

6 A KOAc Toluene 80 >20 : 1 >997 A NaOAc Toluene 82 >20 : 1 >998 A Et3N Toluene 19 — —

9 B NaOAc Toluene 88 >20 : 1 >9910 C NaOAc Toluene 84 >20 : 1 >9911 D NaOAc Toluene 81 >20 : 1 98

12 E NaOAc Toluene 80 >20 : 1 89

13 B NaOAc DCM 81 >20 : 1 >9914 B NaOAc THF <10 — —

15 B NaOAc Mesitylene 93 >20 : 1 >9916 B NaOAc o-Xylene 90 >20 : 1 >9917[e] B NaOAc Mesitylene 78 >20 : 1 >99[a]Standard condition: 1a (0.1mmol), 2a (1.2 equiv), NHC·HX (10mol%), solvent (0.1M), 30°C, 24 h. [b]Yield of the product after column chromatography.[c]Determined via 1H NMR spectroscopy. [d]Determined by chiral HPLC, %ee = ðR‐SÞ/ðR + SÞ ∗ 100. [e]5 mol% catalyst, 60 h.

3Research

Page 4: Desymmetrization of Cyclic 1,3-Diketones under N

achieve satisfactory diastereoselectivity and enantioselectiv-ity would remain important. Importantly, organocatalyzedgeneration of enantioenriched organofluorines preventsheavy metal residues, considerably increasing the potentialutilities. We herein have developed a novel prochiral fluori-nated oxindanyl 1,3-diketone and successfully applied thesesubstrates in carbene-catalyzed asymmetric desymmetriza-tion. Accordingly, a versatile and practical strategy forasymmetric generation of organofluorines with fluorine orfluorinated methyl groups (CF3, CF2H, or CH2F) has beendeveloped. Multiple stereogenic centers were selectively con-structed with satisfactory outcomes. It may be mentionedthat enantioselective synthesis of tricyclic β-lactones byNHC-catalyzed desymmetrization of cyclic 1,3-diketoneshas been demonstrated recently by Shee and coworkers [66].

2. Results

We initially attempted this synthetic approach with pro-chiral trifluoromethylated oxindolyl 1,3-diketone 1a and(Z)-2-bromo-3-phenylacrylaldehyde 2a under NHC orga-nocatalysis. Trifluoromethylated spiropolycyclic compound3a was obtained in 11% yield when sterically hinderedaminoindanol-derived triazolium precatalyst A was employedin the presence of K2CO3 in toluene at room temperature(Table 1, entry 1). Subsequently, several bases were screened,and sodium acetate was the best base, giving the product 3ain good yield (82%) with >20 : 1 dr and >99% ee (entries2-8). Several NHC catalysts were next investigated, withNHC precatalyst B, with a Br atom on the indane moiety,proving to be the better choice to deliver the product 3a in

Ar

PGN

O

O

O

O

O

ON

PG

O

O

O

O

OO

O

ONBn

O

3l, R = 4-F, 86% yield, > 99% ee, > 20:1 dr3m, R = 4-Cl, 93% yield, > 99% ee, > 20:1 dr3n, R = 4-Br, 83% yield, > 99% ee, 15.0:1 dr3o, R = 4-NO2, 78% yield, > 99% ee, 13.0:1 dr3p, R = 4-Me, 87% yield, > 99% ee, > 20:1 dr3q, R = 4-OMe, 83% yield, > 99% ee, > 20:1 dr3r, R = 2-Cl, 91% yield, > 99% ee, > 20:1 dr3s, R = 2-OMe, 71% yield, > 99% ee, > 20:1 dr3t, R = 3-Cl. 93% yield, > 99% ee, > 20:1 dr

OO

Cl

Cl

NMe

3k, 86% yield,> 99% ee, > 20:1 dr

O

O

O ONBn

3v, 96% yield,> 99% ee, > 20:1 dr

O

O

OON

Bn3w, 92% yield,> 99% ee, > 20:1 dr

O

ONBn

3u, 84% yield,> 99% ee, > 20:1 dr

NMe

3j, 83% yield,> 99% ee, > 20:1 dr

3f, 81% yield,> 99% ee, > 20:1 dr

X-ray of 3f ccdc: 2056654

NMe

Br

ON

F

Me

OO

O

O

R

NMe

Me

MeN O

O

OO

ONMe

3a, 93% yield,> 99% ee, > 20:1 dr

3b, 91% yield,> 99% ee, > 20:1 dr

3c, R = OMe, 87% yield, > 99% ee, > 20:1 dr3d, R = Cl, 85% yield, > 99% ee, > 20:1 dr

3e, 90% yield,> 99% ee, > 20:1 dr

3g, PG = Bn, 99% yield,> 99% ee, > 20:1 dr3h, PG = Allyl, 87% yield,> 99% ee, > 20:1 dr3i, PG = i-Pr, 83% yield> 99% ee, > 20:1 dr

O

O

O

OO

PG

Ar

N

+CF3

CF3

CF3CF3

CF3 CF3CF3

CF3

CHOBr

R

Ph

PhPh

Ph Ph Ph

O

O

CF3 CF3 CF3

PhPh

O O OR

O

O OO

R

O

1a 2a 3a

NHC·HBF4 B (10 mol%)NaOAc 1.5 equiv

Mesitylene 0.1 M4 Å Ms, 30 °C, 24 h

CF3CF3 CF3

O

O

O O

S

Figure 2: Scope of reactions.

4 Research

Page 5: Desymmetrization of Cyclic 1,3-Diketones under N

8e, 89% yield, > 99% ee, > 20:1 dr

Figure 3: Scope of reactions.

5Research

Page 6: Desymmetrization of Cyclic 1,3-Diketones under N

high yield without any loss in dr or ee (entries 9–12). The yieldcould be further improved to 93% by using mesitylene as thesolvent (entries 13-16). 5mol% catalyst ensured this transfor-mation to give the product in 78% yield (entry 17).

Under optimal conditions (Table 1, entry 15), the scopeof this desymmetrization domino reaction was examined(Figure 2). For trifluoromethylated oxindolyl 1,3-diketones,several substituents at the 4-, 5-, 6-, and 7-positons on theoxindole ring were well tolerated to form 3a–3f in good toexcellent yields (81-93%) with excellent diastereoselectivities(>20 : 1 dr values) and enantioselectivities (>99% ee values).Substrates with N-benzyl, N-allyl, and N-isopropyl groupsreacted efficiently to form products 3g–3i in 83%–93% yieldsand without any erosion of dr values and ee values. For theindane motif, substrate 1 with a naphthalene unit gave 3j in83% yield with >20 : 1 dr and >99% ee. Introducing two sym-metrical chloride atoms to the indane ring did not influencethe efficiency, furnishing the product 3k in 86% yield with>20 : 1 dr and >99% ee. Subsequently, the generality of 2-bromoenals was evaluated. For 2-bromoenals associated with

electron-donating or electron-withdrawing groups on thearomatic ring, the reactions worked efficiently to afford theproducts 3l-3w in good to excellent yields with good to excel-lent diastereoselectivities and excellent enantioselectivities.Bromoenals with a naphthalene or heteroaryl unit (such as2-furyl and 2-thienyl) were also compatible with the reac-tion. Unfortunately, β-alkyl-substituted enals failed todeliver the product in our reaction.

To further investigate the scope and limitations of thisorganocatalytic strategy, other fluorinatedmethyl groups, suchas difluoromethyl, and monofluoromethyl groups were intro-duced into the prochiral substrates (Figure 3). Notably, forthese substrates, the release of CO2 could not be completelyavoided under the reaction conditions and in the purificationstep that followed. Thus, one more decarbonation operationwas performed for these substrates. Delightingly, all reactionsproceeded smoothly, forming the products 6 and 8 withacceptable results. On the other hand, the intermediate under-went ring opening with a nucleophile, such as methanol, deliv-ering products 5 and 7, respectively. We consider that

Ar O

O+

F

F F F F

O

O

OO

O MeO

MeN O O

O

10d, 93% yield,99% ee, 9.2:1 dr

10g, R = 4-H, 88% yield, 94% ee, 10.0:1 dr10h, R = 4-F, 92% yield, 92% ee, 10.5:1 dr10i, R = 4-NO2, 83% yield, 90% ee, 6.2:1 dr10j, R = 4-Br, 91% yield, 93% ee, 11.0:1 dr10k, R = 4-OMe, 90% yield, 98% ee, 9.0:1 dr10l, R = 4-Me, 89% yield, 95% ee, 10.2:1 dr10m, R = 4-Cl, 86% yield, 92% ee, 8.3:1 dr10n, R = 2-Cl, 89% yield, 99% ee, 10.2:1 dr10o, R = 2-MeO, 95% yield, 96% ee, 7.0:1 dr10p, R = 3-Cl, 95% yield, 93% ee, 3.0:1 dr

10c, 96% yield,98% ee, 10.5:1 dr

O

NMe

O

ClO

OON

Me

10b, 86% yield,> 99% ee, 6.0:1 dr

10a, 92% yield,98% ee, 5.0:1 dr

F

NMe

9 2

Ar

NPG 10

OO

O

FR

Br CHO

O O O O

Ph PhPh

F

FF F

FF

OO

O

O

O

O

O

O

OONO

O

10q, 93% yield,98% ee, 2.6:1 dr

10r, 92% yield,96% ee, 4.0:1 dr

10s, 89% yield,98% ee, 6.0:1 dr

X-ray of 10j ccdc: 2056655

NN

BnBn Bn

N

Me

Me10e, 92% yield,96%, ee, 5.0:1 dr

10f, 93% yield,> 99% ee, 8.5:1 dr

O O

O

O

OON

Bn

ONBrMe

O O

O O

SO

OR

Ph Ph

Ph

O

RNHC·HBF4 B (2 mol%)

base (1.5 equiv)

Mesitylene 0.1 M4 Å MS, 30 °C, 24 hN

PG

Figure 4: Scope of reactions. Reaction conditions: 9 (0.1mmol), 2 (1.2mmol), NHC·HBF4 B (2mol%), NaOAc (1.5mmol), mesitylene(1mL), 4 Å MS (50mg), 30°C, 24 h.

6 Research

Page 7: Desymmetrization of Cyclic 1,3-Diketones under N

asymmetric synthesis of important organofluorines containingCF2H and CFH2 has been overlooked to date [34, 67–69]. Ournovel strategy for asymmetric synthesis of these organofluor-ines by carbene-catalyzed desymmetrization is effective.

After successfully documenting the synthesis of fluoro-methylated molecules with five stereogenic centers underNHC organocatalysis, the generality of this desymmetriza-tion strategy was further explored to construct fluorinatedmolecules (Figure 4). Different from the above-obtainedproducts 3, 5, 6, 7, and 8, which featured the more stericallyhindered fluorinated methyl groups, the resulting product10 featured the relatively small fluorine atom and showedthe opposite absolute configuration under the identical reac-tion conditions. In all the cases, the desymmetrization cas-cade process proceeded smoothly by using just 2mol%carbene catalyst, delivering spirocyclohexene products in86-93% yields with 2.6 : 1-11 : 1 dr and 90-99% ee values.

Under 10mol% of NHC precatalyst B catalysis, the reac-tion worked efficiently on a gram scale to generate 3 g in 88%yield with >20 : 1 dr and >99% ee (Figure 5(a)). To demon-strate the practicality of the present strategy, further synthetictransformation of the resulting product was performed asshown in Figure 2. The substrates 1a with CF3 and 9a withF underwent intramolecular desymmetrical cyclisation,followed by decarbonation to generate the correspondingproducts 11 and 12 in good yields with excellent dr andee values, respectively. Impressively, our method reportedhere is also effective to prepare enantioenriched trifluoro-methylthiolated compounds, leading to product 14 withexcellent yields, dr and ee values (Figure 5(c)). Ring open-ing of the product 3a was achieved by treatment withnucleophiles such as methanol and benzylamine at roomtemperature and led to the formation of amides 15a and15b in excellent outcomes. More importantly, for the

NuH =

OH

O

HO

S

N

NN

OH

MeO

OH

F3C

15c, 86% yield,> 99% ee, > 20:1 dr

15d, 76% yield,> 99% ee, > 20:1 dr

15e, 82% yield,> 99% ee, > 20:1 dr

Cholesterol

Fluphenazine

From adapalene

H

NuH = MeOH: 15a, 88% yield,> 99% ee, > 20: 1 dr

NuH = BnNH2: 15b, 79% yield,> 99% ee, > 20: 1 dr

H

H

O NuPh

ON

MeCF3

MeO

10a, > 99% ee, > 20:1 dr 16a, > 93%, > 99% ee, > 20:1 dr

O

NO

O O O

O

O

OH

N

ii) Na2CO3. 1.5 H2O2TFA, rt, 40 h

Me

17, 72%, > 99% ee, > 20:1 dr

OH

NMe

i) MeOH,DBU

OO

Ph

OMe OMeO

PhPh

FF F

O

O+

NHC·HBF4 B (10 mol%)

NaOAc 1.5 equivmesitylene (0.05 M)4 Å MS, 30 °C, 24 hO

1g, 1.03 g, 2.3 mmol 2a, 1.2 equiv 3g, 1.17g, 88%,> 99% ee, > 20:1 dr

ONBn

O

O

O

O

HBr

Ph

Ph

CF3NBn

O

O

O

O

O 9a

(b)

(a)

(c)

(d)

(e)

2a 12, 85%, 97% ee, 8.0:1 dr

NMe

ONMe

ONMe

11, 87%, > 99% ee, > 20:1 dr

O

O

+

+

ON

Me1a 2a

i) Table 1, entry 11

ii) SiO2, 70 °C, 10 h

i) Table 1, entry 11

ii) SiO2, 70 °C, 10 h

O

O

H

H

Br

Br

Ph

Ph

Ph

Ph

CF3

F F

CF3

CF3

NaOAc 1.5 equivmesitylene (0.1 M)4 Å MS, 30 °C, 24 h

O

O

O13 2a

NHC·HBF4 B (10 mol%)

NMe

O

ONMe

14, 81% yield, > 99% ee, > 20:1 dr

O+

OO

HBr

Ph Ph

SCF3SCF3

Figure 5: Synthetic application: (a) gram scale synthesis; (b) one pot process to enantioenriched spirocyclohexene product; (c) synthesis ofenantioenriched trifluoromethylthiolated spirocyclohexene product; (d) one pot process to cycle-open product; (e) Baeyer-Villiger oxidationof the enantioenriched product.

7Research

Page 8: Desymmetrization of Cyclic 1,3-Diketones under N

alcohols with promising biological activities, such as choles-terol, fluphenazine, and adapalene-derived alcohol, thering-opened products 15c-e were formed in good yields withexcellent dr and ee (or de) values. The treatment of 10a withmethanol under basic conditions followed by oxygen inser-tion converted the carbonyl moiety into a carboxylic moiety,leading to product 17 in good yield with the retention of drand ee.

DFT calculations were conducted to explore the possiblepathway. As shown in Figure 6, the carbonyl carbon of reac-tant 1a is susceptible to nucleophilic attack by the carbenecarbon of the actual NHC catalyst via transition state TS1,which is followed by an acetic acid-mediated [1, 2]-protontransfer via transition state TS2 for the formation of Breslowintermediate M2. The third step is a bromide removal pro-cess via transition state TS3. Deprotonation can then bemediated by bromide ion, coupled with protonation by aceticacid via transition state TS4. The fifth step involves diastereo-selective transition state TS5SS (or TS5RR) for Cβ–C1 bondformation between intermediate M4 and deprotonated achi-ral 1,3-diketone 2a-, which is followed by an intramolecular[2 + 2] cycloaddition to complete the six-membered ring clo-sure via transition state TS6SS. The two letters after thenames of the stationary points represent the chirality of the

molecules associated with the centrally chiral C1 and Cβatoms. The last step is the dissociation of catalyst NHC fromthe main product PSS via transition state TS7SS. The Gibbsfree energy barriers of the seven steps via transition statesTS1-7 are 4.3, 6.3, 1.7, 18.2, 9.5 (or 12.6 for RR-configuredisomer), 8.8, and 5.4 kcal/mol, respectively.

To further examine the origin of enantioselectivity, quan-titative Bader atoms-in-molecules analyses were carried out.The energy barrier of transition state TS5RR is 3.1 kcal/molhigher than that of transition state TS5SS, whereas the energybarrier of the transition state TS5RR′ is 2.2 kcal/mol lowerthan that of transition state TS5SS′ (Figure 7(a)), meaningthat the enantioselectivity can be switched by exchangingthe -CF3 substituent with -F. As shown in Figures 3(b) and3(c), there are no C-H…F hydrogen bond [70] and (long pair)LP…π interaction in the TS5RR (RR-configured transitionstate), which is due to the long distance between the -CF3 sub-stituent and NHC catalyst in the RR-configuration. This iswhy TS5SS is more stable than TS5RR. While the -CF3 sub-stituent is replaced by the small -F group, although there isstill not C-H…F interaction, the C-H…O hydrogen bondinteractions between the substrate and NHC catalyst inTS5RR′ become significantly stronger than those of C-H…Oand C-H…F hydrogen bond interactions in transition state

𝛥G (kcal/mol)

TS1 NHC =

Br

HOAc

HOAc

H

O

Br

Br–

Ph

HOAc

HBr

TS2TS3

TS4

7.0

2a–

2a–O

O

O++

++

++

++ ++

++

++

O

O

O

PhPh

BrBr

Br

Br

BrHO

HH

HH PhPh

Ph

Ph

HH

HH

Ph

PhOAc

C

Br

HO HO

HH

H HPhPh Ph Ph–

O–

OO –

O

OO

O

HPh

PhO

OON

PSS

O

NHC

N

TS7SS

TS6SS

TS7SS

NHC

ON–

–OAc

+

M1

M1 M2

NHC

1a =

M2

NHC

NHC

+NHC

+NHC

+NHC

+NHC

+NHC

O–

O O

OO O

OON

OOO

N NON

TS5SSAddition of

NHC[1, 2]-proton

transferBromide removal

processProton transfer

processC-C bondformation

[2+2]cycloaddition

Regenerationof NHC

TS6SS M6SSM5SS

+NHC

+NHC +

NHC

+NHC

TS1 TS2

M3 M4TS3 TS4

M3

M4–1.6

–7.9

–4.5–2.8

–11.2

–5.3

–23.7

–32.5M5SS –36.2

–42.8M6SS

PSS–46.4

4.2TS5SS

TS5RR7.3

CF3

CF3

CF3

CF3CF3F3CF3C

MesN

NN

O

4.3

0.01a+NHC

⁎⁎

⁎⁎

⁎⁎

OO

O –O

⁎⁎

⁎⁎

Figure 6: Gibbs free energy profile of the entire catalytic cycle computed at the M06-2X/6-31G(d, p)/IEFPCM mesitylene level.

8 Research

Page 9: Desymmetrization of Cyclic 1,3-Diketones under N

TS5SS′, which is the key factor in strengthening the stability ofthe RR-configured transition state TS5RR′ and leads to theswitchable stereoselectivity for the reaction. Noteworthily, 20possible conformations for TS5SS, TS5RR, TS5SS′, andTS5RR′ were proposed and optimized to ensure that the con-formation with the lowest energy was selected. The calculatedresults were provided in Figure S1 of the SI.

To show the practical value of the resulting enantioen-riched fluorinated and fluoromethylated molecules, theirantibacterial activities were initially examined by usingXanthomonas oryzae, Xanthomonas axonopodis, and Ral-stonia solanacearum as target bacteria [71–73]. These bac-teria are widespread plant pathogens that can causeserious plant diseases and huge economic losses in agricul-tural production [74]. Some of the chiral organofluorinesfrom the current study exhibited superior antibacterialactivities, as shown in Table 2. For example, compounds10a and 8b showed higher inhibitory rates against Xoo thanthe commercial bacteriocide bismerthiazol when used at50μg/mL. Similarly, compounds 6b and 16 showed inhibi-

tory rates against Xal that were similar to thiodiazole-copper.Under the same conditions, compounds 12 and 15a showedbetter inhibitory rates against Rs than thiodiazole-copper.These promising results indicated that the organofluorinesproduced in the current study have potential use asagrochemicals.

3. Discussion

In summary, asymmetric desymmetrization of a novel pro-chiral 1,3-diketone with a fluorine or fluorinated methylgroup has been demonstrated under NHC organocatalysis.Accordingly, a versatile and practical strategy for the con-struction of diverse organofluorines featuring fluorine orfluoromethyl groups (CF3, CF2H, or CH2F) has been success-fully developed by the current strategy. Notably, products fea-turing five stereogenic centers, including three quaternarycenters and two rings, have been efficiently constructed in thistransformation. Mechanism studies and DFT calculationsdemonstrated that the first C-C bond formation is the

PhO

H

+NHC

O

++

ON

OTS5SS (𝛥𝛥G≠ = 0.0) TS5RR (𝛥𝛥G≠ = 3.1) TS5SS′ (𝛥𝛥G≠ = 0.0) TS5RR′ (𝛥𝛥G≠ = –2.2)

F3C

⁎Ph

O

H

+NHC

O

++

ON

OF3C

⁎Ph

O

H

+NHC

O

++

ON

OF

⁎Ph

O

H

+NHC

O

++

ON

OF

1. 2.05 Å2. 2.75 Å3. 3.15 Å4. 2.37 Å

1. 2.06 Å2. 2.25 Å3. 2.94 Å4. 2.45 Å

3. 3.01 Å4. 2.45 Å5. 3.16 Å6. 2.50 Å7. 2.57 Å

5. 2.75 Å6. 3.16 Å7. 2.56 Å

1. 1.86 Å2. 2.35 Å7

3

3 2

415

Br Br

Br

3 451

627

1

2

6

3

54

1 4

25 6

Br

5. 2.52 Å6. 3.19 Å

1. 2.05 Å2. 2.23 Å3. 2.45 Å

4. 3.13 Å5. 3.01 Å

TS5SS TS5RR TS5SS′ TS5RR′CNO

FH

(a)

(b)

(c)

TS5SS (𝛥𝛥G≠ = 0.0)Type ∇2𝜌 Type ∇2𝜌 Type ∇2𝜌 Type ∇2𝜌

0.5140.5510.4150.4040.3540.3530.339

1.060.5220.3750.3130.294

0.7890.5840.4160.3590.3540.321

0.8010.5980.4280.3430.3290.3140.310

1234567

C-H...OLP...πLP...πC-H...OC-H...Brπ...πC-H...F

C-H...OC-H...OLP...πC-H...ππ...πC-H...OC-H...O

C-H...OC-H...OLP...πC-H...FC-H...Oπ...π

C-H...OC-H...OC-H...Oπ...πC-H...π

TS5RR (𝛥𝛥G≠ = 3.1) TS5SS′ (𝛥𝛥G≠ = 0.0) TS5RR′ (𝛥𝛥G≠ = –2.2)

Figure 7: (a) The Gibbs free energy barrier differences (ΔΔG≠, energy in kcal/mol), (b) AIM analyses for transition states TS5SS, TS5RR,TS5SS′, and TS5RR′ with different substitutes (distance in Å), and (c) summary of the values of Laplacian electron density (∇2ρ in eÅ-3).

9Research

Page 10: Desymmetrization of Cyclic 1,3-Diketones under N

Table2:The

antibacterialactivityof

theprod

ucts.

Com

poun

dXanthom

onas

oryzae

pv.oryzae(Xoo)inhibition

rate

50pp

mXanthom

onas

axon

opod

ispv.citri(Xal)inhibition

rate

50pp

mRalston

iasolanacearum

(Rs)inhibition

rate

50pp

m

3a0:00%±9:86%

44:30%

±3:66%

0:00%±4:53%

6b74:71%

±10:22%

73:14%

±6:77%

78:26%

±4:53%

8b99:69%

±7:57%

64:75%

±3:60%

38:90%

±13:88%

10a

93:40%

±21:20%

41:87%

±4:98%

58:95%

±4:70%

1121:46%

±1:91%

35:69%

±1 1:07%

47:03%

±6:87%

120 :00%±19:67%

41:28%

±2:90%

94:57%

±0:55%

15a

3:90%±0:11%

41:65%

±6:29%

99:69%

±18:24%

160:00%±5:79%

70:42%

±12:69%

0:00%

±5:57%

Thiodiazole-cop

per

89:29%

±1 0:69%

79:32%

±0:64%

93:29%

±1:19%

Bismerthiazol

94:39%

±22:58%

54:67%

±1:22%

47:40%

±7:43%

OO

O

OO

OO

O

O

OH

OH

OO

1112

15a

10a

8b6b

3a

16

OO

NN

Me

Me

O

O

OO

ON

Me

NM

e

NN

Me

Me

N

Me

N

Me

CF3

CF3

CF3CH

2FCF

2H

F

F

F

O

O

OM

eO

OM

e

Ph

O

PhPh

PhPh

PhPh

Ph

10 Research

Page 11: Desymmetrization of Cyclic 1,3-Diketones under N

stereoselectivity-determining step as well as C-H…O andC-H…F interactions are the key factors to control and evenswitch the enantioselectivity of the reaction by exchangingthe fluoromethyl substituents. The initial test indicated thatsome of the obtained enantioenriched organofluorinesshowed competitive antibacterial activities. Further investi-gations and exploration of this catalytic process and theresulting enantioenriched organofluorines are underway inour laboratory.

4. Materials and Methods

4.1. General Procedure for the Synthesis of Organofluorine 3.To an oven-dried screw-capped test tube equipped with amagnetic stir bar, the prochiral 1,3-diketones 1 (0.1mmol),2-bromoenals 2 (0.12mmol), triazolium salt NHC B(5.0mg, 10mol %), NaOAc (12.3mg, 1.5 equiv), and 4ÅMS (50mg) were added. To this mixture was added anhy-drous mesitylene (0.1M). After completion of the reaction,purification of the crude residue gave the desired product 3.

Data Availability

The data that support the finding of this study are availablefrom the corresponding authors upon reasonable request.

Conflicts of Interest

The authors declare that there is no conflict of interestregarding the publication of this article.

Authors’ Contributions

Z.F. conceived the idea and designed the experiments. Z.F.,D.W., R.Y.C., and W.H. supervised the work. G.W. con-ducted most of the experiments. Y.Z., X.H., and C.W. pre-pared some of starting materials. M.Z. performed the DFTstudy. Y.G. and P.Z. performed antibacterial activity tests.Z.F. drafted the manuscript with assistance from all coau-thors. All authors contributed to discussions.

Acknowledgments

This work was supported by the National Key R&D Programof China (2017YFA0204704), National Natural ScienceFoundation of China (21602105), and Natural ScienceFoundation of Jiangsu Province (BK20171460). G. Wangis grateful to the Cultivation Program for Excellent Doc-toral Dissertation of Nanjing Tech University for financialsupport.

Supplementary Materials

Preparation of substrates. Characterization of reaction sub-strates. General procedures. Characterization of reactionproducts. X-ray crystallographic data of 3f and 10j. Compu-tational details. In vitro antibacterial bioassay. Copies ofNMR spectra and HPLC chromatographs. Energies, Carte-sian coordinates, and frequencies of all the optimized station-ary points in DFT studies. (Supplementary Materials)

References

[1] A. Borissov, T. Q. Davies, S. R. Ellis, T. A. Fleming, M. S. W.Richardson, and D. J. Dixon, “Organocatalytic enantioselectivedesymmetrisation,” Chemical Society Reviews, vol. 45, no. 20,pp. 5474–5540, 2016.

[2] X.-P. Zeng, Z.-Y. Cao, Y.-H.Wang, F. Zhou, and J. Zhou, “Cat-alytic enantioselective desymmetrization reactions to all-carbon quaternary stereocenters,” Chemical Reviews, vol. 116,no. 12, pp. 7330–7396, 2016.

[3] T. Das, “Desymmetrization of cyclopentene-1,3-diones viaalkylation, arylation, amidation and cycloaddition reactions,”ChemistrySelect, vol. 5, no. 45, pp. 14484–14509, 2020.

[4] T. Shu and J. Cossy, “Asymmetric desymmetrization ofalkene-, alkyne- and allene-tethered cyclohexadienones usingtransition metal catalysis,” Chemical Society Reviews, vol. 50,no. 1, pp. 658–666, 2021.

[5] B. M. Bocknack, L.-C. Wang, and M. J. Krische, “Desymmetri-zation of enone-diones via rhodium-catalyzed diastereo- andenantioselective tandem conjugate addition-aldol cyclization,”Proceedings of the National Academy of Sciences of the UnitedStates of America, vol. 101, no. 15, pp. 5421–5424, 2004.

[6] M. Wadamoto, E. M. Phillips, T. E. Reynolds, and K. A.Scheidt, “Enantioselective synthesis of α,α-disubstituted cyclo-pentenes by anN-Heterocyclic carbene-catalyzed desymmetri-zation of 1,3-diketones,” Journal of the American ChemicalSociety, vol. 129, no. 33, pp. 10098-10099, 2007.

[7] B. M. Partridge, J. Solana González, and H. W. Lam, “Iridium-catalyzed arylative cyclization of alkynones by 1,4-iridiummigration,” Angewandte Chemie International Edition,vol. 53, no. 25, pp. 6523–6527, 2014.

[8] X. Wu, Z. Chen, Y.-B. Bai, and V. M. Dong, “Diastereodiver-gent construction of bicyclic γ-lactones via enantioselectiveketone hydroacylation,” Journal of the American ChemicalSociety, vol. 138, no. 37, pp. 12013–12016, 2016.

[9] C. Zhu, D. Wang, Y. Zhao, W.-Y. Sun, and Z. Shi, “Enantiose-lective palladium-catalyzed intramolecular α-arylative desym-metrization of 1,3-diketones,” Journal of the AmericanChemical Society, vol. 139, no. 46, pp. 16486–16489, 2017.

[10] S. Cuadros, L. Dell'Amico, and P. Melchiorre, “Forgingfluorine-containing quaternary stereocenters by a light-driven organocatalytic aldol desymmetrization process,”Ange-wandte Chemie International Edition, vol. 56, no. 39,pp. 11875–11879, 2017.

[11] L. Cai, K. Zhang, S. Chen et al., “Catalytic asymmetricStaudinger-azaWittig reaction for the synthesis of heterocyclicamines,” Journal of the American Chemical Society, vol. 141,no. 24, pp. 9537–9542, 2019.

[12] X. Chen, H. Zhang, M. A. Maria-Solano et al., “Efficient reduc-tive desymmetrization of bulky 1,3-cyclodiketones enabled bystructure-guided directed evolution of a carbonyl reductase,”Nature Catalysis, vol. 2, no. 10, pp. 931–941, 2019.

[13] Q. Gong, J. Wen, and X. Zhang, “Desymmetrization of cyclic1,3-diketonesviaIr-catalyzed hydrogenation: an efficientapproach to cyclic hydroxy ketones with a chiral quaternarycarbon,” Chemical Science, vol. 10, no. 25, pp. 6350–6353,2019.

[14] C.-B. Yu, B. Song, M.-W. Chen, H.-Q. Shen, and Y.-G. Zhou,“Construction of multiple-substituted chiral cyclohexanesthrough hydrogenative desymmetrization of 2,2,5-trisubsti-tuted 1,3-cyclohexanediones,” Organic Letters, vol. 21, no. 23,pp. 9401–9404, 2019.

11Research

Page 12: Desymmetrization of Cyclic 1,3-Diketones under N

[15] T. Zhu, Y. Liu, M. Smetankova et al., “Carbene‐catalyzeddesymmetrization and direct construction of arenes with all‐carbon quaternary chiral center,” Angewandte Chemie Inter-national Edition, vol. 58, no. 44, pp. 15778–15782, 2019.

[16] J. M. Zanghi, S. Liu, and S. J. Meek, “Enantio- and diastereose-lective synthesis of functionalized carbocycles by Cucatalyzedborylative cyclization of alkynes with ketones,” Organic Let-ters, vol. 21, no. 13, pp. 5172–5177, 2019.

[17] J. Chen, Y. Wang, Z. Ding, andW. Kong, “Synthesis of bridgedtricyclo[5.2.1.01,5]decanes via nickel-catalyzed asymmetricdomino cyclization of enynones,” Nature Communications,vol. 11, no. 1, pp. 1882–1890, 2020.

[18] Y.-X. Ding, Z.-H. Zhu, H. Wang, C.-B. Yu, and Y.-G. Zhou,“Construction of three stereocenters via hydrogenativedesymmetrization of 2,2,5-trisubstituted cyclohexane-1,3-diones,” Science China: Chemistry, vol. 64, no. 2, pp. 232–237,2021.

[19] B. Yang, J. Dai, Y. Luo et al., “Desymmetrization of 1,3-dionesby catalytic enantioselective condensation with hydrazine,”Journal of the American Chemical Society, vol. 143, no. 11,pp. 4179–4186, 2021.

[20] X.-L. Qin, A. Li, and F.-S. Han, “Desymmetric enantioselec-tive reduction of cyclic 1,3-diketones catalyzed by arecyclableP-chiral phosphinamide organocatalyst,” Journal ofthe American Chemical Society, vol. 143, no. 7, pp. 2994–3002, 2021.

[21] B. Ghosh, R. Balhara, G. Jindal, and S. Mukherjee, “Catalyticenantioselective desymmetrizing Fischer indolization throughdynamic kinetic resolution,” Angewandte Chemie Interna-tional Edition, vol. 60, no. 16, pp. 9086–9092, 2021.

[22] S. Prévost, N. Dupré, M. Leutzsch, Q. Wang, V. Wakchaure,and B. List, “Catalytic asymmetric Torgov cyclization: a con-cise total synthesis of (+)-estrone,” Angewandte Chemie Inter-national Edition, vol. 53, no. 33, pp. 8770–8773, 2014.

[23] M. Wang, M. Feng, B. Tang, and X. Jiang, “Recent advances ofdesymmetrization protocol applied in natural product totalsynthesis,” Tetrahedron Letters, vol. 55, no. 52, pp. 7147–7155, 2014.

[24] P. Kirsch, Modern Fluoroorganic Chemistry, Wiley-VCH,Weinheim, 2013.

[25] K. Muller, C. Faeh, and F. Diederich, “Fluorine in pharmaceu-ticals: looking beyond intuition,” Science, vol. 317, no. 5846,pp. 1881–1886, 2007.

[26] S. Purser, P. R. Moore, S. Swallow, and V. Gouverneur, “Fluo-rine in medicinal chemistry,” Chemical Society Reviews,vol. 37, no. 2, pp. 320–330, 2008.

[27] J. Wang, M. Sánchez-Roselló, J. L. Aceña et al., “Fluorine inpharmaceutical industry: fluorine-containing drugs intro-duced to the market in the last decade (2001-2011),” ChemicalReviews, vol. 114, no. 4, pp. 2432–2506, 2014.

[28] Q. A. Huchet, B. Kuhn, B. Wagner et al., “Fluorination pat-terning: a study of structural motifs that impact physicochem-ical properties of relevance to drug discovery,” Journal ofMedicinal Chemistry, vol. 58, no. 22, pp. 9041–9060, 2015.

[29] E. P. Gillis, K. J. Eastman, M. D. Hill, D. J. Donnelly, and N. A.Meanwell, “Applications of fluorine in medicinal chemistry,”Journal of Medicinal Chemistry, vol. 58, no. 21, pp. 8315–8359, 2015.

[30] J. Fried and E. F. Sabo, “9α-Fluoro derivatives of cortisone andhydrocortisone,” Journal of the American Chemical Society,vol. 76, no. 5, pp. 1455-1456, 1954.

[31] D. O’Hagan and D. B. Harper, “Fluorine-containing naturalproducts,” Journal of Fluorine Chemistry, vol. 100, no. 1-2,pp. 127–133, 1999.

[32] T. Furuya, A. S. Kamlet, and T. Ritter, “Catalysis for fluorina-tion and trifluoromethylation,” Nature, vol. 473, no. 7348,pp. 470–477, 2011.

[33] V. Gouverneur and K. Seppelt, “Introduction: fluorine chemis-try,” Chemical Reviews, vol. 115, no. 2, pp. 563–565, 2015.

[34] X. Y. Yang, T. Wu, R. J. Phipps, and F. D. Toste, “Advances incatalytic enantioselective fluorination, mono-, di-, and tri-fluoromethylation, and trifluoromethylthiolation reactions,”Chemical Reviews, vol. 115, no. 2, pp. 826–870, 2015.

[35] H. Groult, F. Leroux, and A. Tressaud, Modern Synthesis Pro-cesses and Reactivity of Fluorinated Compounds, AcademicPress, London, 2017.

[36] Y. Zhu, J. Han, J. Wang et al., “Modern approaches for asym-metric construction of carbon-fluorine quaternary stereogeniccenters: synthetic challenges and pharmaceutical needs,”Chemical Reviews, vol. 118, no. 7, pp. 3887–3964, 2018.

[37] N. Shibata, A. Matsnev, and D. Cahard, “Shelf-stable electro-philic trifluoromethylating reagents: a brief historical perspec-tive,” Beilstein Journal of Organic Chemistry, vol. 6, p. 65, 2010.

[38] P. A. Champagne, J. Desroches, J.-D. Hamel, M. Vandamme,and J.-F. Paquin, “Monofluorination of organic compounds:10 years of innovation,” Chemical Reviews, vol. 115, no. 17,pp. 9073–9174, 2015.

[39] C. Ni, M. Hu, and J. Hu, “Good partnership between sulfurand fluorine: sulfur-based fluorination and fluoroalkylationreagents for organic synthesis,” Chemical Reviews, vol. 115,no. 2, pp. 765–825, 2015.

[40] J. Charpentier, N. Früh, and A. Togni, “Electrophilic trifluoro-methylation by use of hypervalent iodine reagents,” ChemicalReviews, vol. 115, no. 2, pp. 650–682, 2015.

[41] J. Kalim, T. Duhail, T.-N. Le et al., “Merging hypervalentiodine and sulfoximine chemistry: a new electrophilic trifluor-omethylation reagent,” Chemical Science, vol. 10, no. 45,pp. 10516–10523, 2019.

[42] M. Li, X.-S. Xue, and J.-P. Cheng, “Establishing cation and rad-ical donor ability scales of electrophilic F, CF3, and SCF3trans-fer reagents,” Accounts of Chemical Research, vol. 53, no. 1,pp. 182–197, 2020.

[43] D. Enders, O. Niemeier, and A. Henseler, “Organocatalysis byN-heterocyclic carbenes,” Chemical Reviews, vol. 107, no. 12,pp. 5606–5655, 2007.

[44] X. Bugaut and F. Glorius, “Organocatalytic umpolung:N-heterocyclic carbenes and beyond,” Chemical SocietyReviews, vol. 41, no. 9, pp. 3511–3522, 2012.

[45] D. T. Cohen and K. A. Scheidt, “Cooperative Lewis acid/N-heterocyclic carbene catalysis,” Chemical Science, vol. 3,no. 1, pp. 53–57, 2012.

[46] S. De Sarkar, A. Biswas, R. C. Samanta, and A. Studer, “Catal-ysis with N-heterocyclic carbenes under oxidative conditions,”Chemistry - A European Journal, vol. 19, no. 15, pp. 4664–4678, 2013.

[47] S. J. Ryan, L. Candish, and D. W. Lupton, “Acyl anion freeN-heterocyclic carbene organocatalysis,” Chemical SocietyReviews, vol. 42, no. 12, pp. 4906–4917, 2013.

[48] M. N. Hopkinson, C. Richter, M. Schedler, and F. Glorius, “Anoverview of N-heterocyclic carbenes,” Nature, vol. 510,no. 7506, pp. 485–496, 2014.

12 Research

Page 13: Desymmetrization of Cyclic 1,3-Diketones under N

[49] D. M. Flanigan, F. Romanov-Michailidis, N. A. White, andT. Rovis, “Organocatalytic reactions enabled by N-heterocyclic carbenes,” Chemical Reviews, vol. 115, no. 17,pp. 9307–9387, 2015.

[50] X. Y. Chen, Z. H. Gao, and S. Ye, “Bifunctional N-heterocycliccarbenes derived from L-pyroglutamic acid and their applica-tions in enantioselective organocatalysis,” Accounts of Chemi-cal Research, vol. 53, no. 3, pp. 690–702, 2020.

[51] H. Ohmiya, “N-Heterocyclic carbene-based catalysis enablingcross-coupling reactions,” ACS Catalysis, vol. 10, no. 12,pp. 6862–6869, 2020.

[52] X. Chen, H. Wang, Z. Jin, and Y. R. Chi, “N‐Heterocycliccar-bene organocatalysis: activation modes and typical reactiveintermediates,” Chinese Journal of Chemistry, vol. 38, no. 10,pp. 1167–1202, 2020.

[53] Y. Zhang, J. Huang, Y. Guo, L. Li, Z. Fu, and W. Huang,“Access to enantioenriched organosilanes from enals andβ-silyl enones: carbene organocatalysis,” Angewandte Che-mie, International Edition, vol. 57, no. 17, pp. 4594–4598,2018.

[54] Y. Gao, D. Liu, Z. Fu, and W. Huang, “Facile synthesis of2,2-diacyl spirocyclohexanones via an N-heterocycliccarbene-catalyzed formal [3C + 3C] annulation,” OrganicLetters, vol. 21, no. 4, pp. 926–930, 2019.

[55] G. Wang, Q. Shi, W. Hu et al., “Organocatalytic asymmetric_N_ -sulfonyl amide C-N bond activation to access axially chi-ral biaryl amino acids,”Nature Communications, vol. 11, no. 1,p. 946, 2020.

[56] Y. Zhang, X. Huang, J. Guo, C. Wei, M. Gong, and Z. Fu, “Car-bene-catalyzed enantioselective synthesis of γ-keto-β-silylesters and amides,” Organic Letters, vol. 22, no. 24, pp. 9545–9550, 2020.

[57] G. Wang, Q.-C. Zhang, C. Wei et al., “Asymmetric carbene-catalyzed oxidation of functionalized aldimines as 1,4-dipoles,” Angewandte Chemie, International Edition, vol. 60,no. 14, pp. 7913–7919, 2021.

[58] A. Ding, M. Meazza, H. Guo, J. W. Yang, and R. Rios, “Newdevelopment in the enantioselective synthesis of spiro com-pounds,” Chemical Society Reviews, vol. 47, no. 15, pp. 5946–5996, 2018.

[59] P.-W. Xu, J.-S. Yu, C. Chen, Z.-Y. Cao, F. Zhou, and J. Zhou,“Catalytic enantioselective construction of spiro quaternarycarbon stereocenters,” ACS Catalysis, vol. 9, no. 3, pp. 1820–1882, 2019.

[60] L. Hong and R. Wang, “Recent advances in asymmetricorganocatalytic construction of 3,3′-spirocyclic oxindoles,”Advanced Synthesis & Catalysis, vol. 355, no. 6, pp. 1023–1052, 2013.

[61] D. Cheng, Y. Ishihara, B. Tan, and C. F. Barbas III, “Organoca-talytic asymmetric assembly reactions: synthesis of spirooxin-doles via organocascade strategies,” ACS Catalysis, vol. 4,no. 3, pp. 743–762, 2014.

[62] B. Yu, D.-Q. Yu, and H.-M. Liu, “Spirooxindoles: promisingscaffolds for anticancer agents,” European Journal of MedicinalChemistry, vol. 97, pp. 673–698, 2015.

[63] J. Mahatthananchai and J. W. Bode, “On the mechanism ofN-heterocyclic carbene-catalyzed reactions involving acylazoliums,” Accounts of Chemical Research, vol. 47, no. 2,pp. 696–707, 2014.

[64] S. Mondal, S. R. Yetra, S. Mukherjee, and A. T. Biju, “NHC-catalyzed generation of α,β-unsaturated acylazoliums for the

enantioselective synthesis of heterocycles and carbocycles,”Accounts of Chemical Research, vol. 52, no. 2, pp. 425–436,2019.

[65] A. Ghosh and A. T. Biju, “Revealing the similarities ofα,β-unsaturated iminiums and acylazoliums in organocata-lysis,” Angewandte Chemie International Edition, vol. 60,no. 25, pp. 13712–13724, 2021.

[66] S. Shee, S. Mukherjee, R. G. Gonnade, and A. T. Biju, “Enantio-selective synthesis of tricyclic β-lactones by NHC-catalyzeddesymmetrization of cyclic 1,3-diketones,” Organic Letters,vol. 22, no. 14, pp. 5407–5411, 2020.

[67] J.-A. Ma and D. Cahard, “Asymmetric fluorination, trifluoro-methylation, and perfluoroalkylation reactions,” ChemicalReviews, vol. 104, no. 12, pp. 6119–6146, 2004.

[68] Z. Feng, Y.-L. Xiao, and X. Zhang, “Transition-metal (Cu, Pd,Ni)-catalyzed difluoroalkylation via cross-coupling withdifluoroalkyl halides,” Accounts of Chemical Research, vol. 51,no. 9, pp. 2264–2278, 2018.

[69] X.-S. Hu, J.-S. Yu, and J. Zhou, “Catalytic selective mono- anddifluoroalkylation using fluorinated silyl enol ethers,” Chemi-cal Communications, vol. 55, no. 91, pp. 13638–13648, 2019.

[70] Y.-J. Hao, J. S. Yu, Y. Zhou, X. Wang, and J. Zhou, “Influenceof C-F…H-X interactions on organic reactions,” Acta ChimicaSinica, vol. 76, no. 12, pp. 925–939, 2018.

[71] T. R. Gottwald, G. Hughes, J. H. Graham, X. Sun, and T. Riley,“The citrus canker epidemic in Florida: the scientific basis ofregulatory eradication policy for an invasive species,” Phytopa-thology, vol. 91, no. 1, pp. 30–34, 2001.

[72] P. Li, D. Hu, D. Xie, J. Chen, L. Jin, and B. Song, “Design, syn-thesis, and evaluation of new sulfone derivatives containing a1,3,4-oxadiazole moiety as active antibacterial agents,” Journalof Agricultural and Food Chemistry, vol. 66, no. 12, pp. 3093–3100, 2018.

[73] P. Y. Wang, M. W. Wang, D. Zeng et al., “Rational optimiza-tion and action mechanism of novel imidazole (or imidazo-lium)-labeled 1,3,4-oxadiazole thioethers as promisingantibacterial agents against plant bacterial diseases,” Journalof Agricultural and Food Chemistry, vol. 67, no. 13,pp. 3535–3545, 2019.

[74] Q. L. Dang, W. K. Kim, C. M. Nguyen et al., “Nematicidal andantifungal activities of Annonaceous acetogenins fromAnnonasquamosaagainst various plant pathogens,” Journal of Agricul-tural and Food Chemistry, vol. 59, no. 20, pp. 11160–11167,2011.

13Research